Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Q&A: Why repeal-and-replace of the ACA isn’t dead

Years of efforts by Republicans to repeal and/or repeal the Affordable Care (ACA) culminated in a dramatic early-morning defeat as three GOP senators voted against the rest of their party. Which leaves the healthcare industry wondering: What now?

FDA introduces 'action plan' to improve digital innovation in healthcare

The U.S. Food and Drug Administration (FDA) has released its “Digital Health Innovation Action Plan” to provide guidance on medical devices and software in the 21st Century Cures Act. The Center for Devices and Radiological Health (CDRH) was launched as a pilot precertification program for the development of digital health technology.

Thumbnail

CMS outlines how it will cut $43B from Medicaid DSH payments

A proposed rule from CMS offered greater detail on the methodology for implementing the Affordable Care Act’s $43 billion in cuts to Medicaid Disproportionate Share Hospital (DSH) payments between 2018 and 2025.

UnitedHealth accused of hiding complaints of Medicare Advantage fraud

The largest Medicare Advantage insurer, UnitedHealth, allegedly concealed hundreds of complaints about fraud and misconduct among its MA sales staff from the federal government to receive payments to which it wasn’t entitled, according to a newly unsealed whistleblower lawsuit.

Thumbnail

AHA names Atlantic Health’s Gragnolati as chair-elect designate

Brian Gragnolati, president and CEO of Morristown, New Jersey-based Atlantic Health System, has been selected to become chairman of the American Hospital Association’s board of trustees beginning in 2019.

FDA approved implantable device opens doors for technology within the body

Nucleus 7, a device from Apple and Cochlear, a hearing assistance company, is a surgically implanted sound processor connected to the iPhone to improve the quality of life for impaired patients.

Thumbnail

ACA repeal bill fails in dramatic vote; healthcare groups now seek ‘bipartisan effort’

The decisive vote to repeal and/or replace the Affordable Care Act (ACA) ended in an early-morning defeat for Republican opponents of the law, as three GOP senators—Sens. Susan Collins of Maine, Lisa Murkowski of Alaska and John McCain of Arizona—voted no on the so-called “skinny repeal” plan.

Thumbnail

Annual IT costs as high as $19,000 per doctor for some practices

In 2016, physician-owned practices spent between $2,000 and $4,000 more on IT expenses per full-time-equivalent (FTE) physician, according to Medical Group Management Association’s (MGMA) annual DataDive Cost and Revenue Survey.

Displaying 4393 - 4400 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup